A new and potentially extremely beneficial Alzheimer’s treatment is about to move into its next level of testing. Recently, the National Institutes of Health announced that the experimental drug BPN14770 is poised to begin clinical trials on human subjects. BPN14770 appears to have less potential side effects than its precursor, rolipram, and the new drug also shows promising results in enhancing memory and cognitive performance in mice impacted by Alzheimer’s.
The first phase of the study will involve testing the safety of the drug in 48 healthy human volunteers, and based on those results, will then move into testing its effects on cognitive functioning, memory and learning abilities.
Unlike other studies currently underway focused on targeting amyloid plaques, BPN14770’s intended outcome is to enhance the biochemical pathway in the brain that’s responsible for formation of nerve synapses and memory. Ideally, the use of BPN14770 can eventually also aid in treating other neurological conditions, such as schizophrenia, Fragile X syndrome, and developmental disabilities.
The Regency Home Care team will continue to keep you updated on the progression of these exciting new developments in the quest to overcome the challenges of Alzheimer’s!
At Regency Home Care, we understand that an Alzheimer’s or dementia diagnosis can present families with a number of difficult decisions, including where the senior should live and receive care. Our top rated Alzheimer’s caregivers can help seniors with Alzheimer’s in a number of ways, from planning and preparing healthy meals to developing engaging and stimulating activities to providing respite care when family caregivers need a break. Contact our home care team today to learn more about our senior care services in Atlanta, GA and our Residences by Regency nursing home alternative.